On October 8, ARM Holdings fell 3.13% in regular trading, trading at $281.74/share, with turnover of $96.767 million.

The latest catalyst stems from the escalating contract dispute between Qualcomm and Arm in Delaware federal court, which has entered jury trial. Market concerns are mounting that prolonged litigation could disrupt Arm's licensing fee revenue. Arm has categorically denied the allegations and argued that Qualcomm failed to demonstrate any actual damages. The ongoing dispute, which originated from Qualcomm's 2021 acquisition of Nuvia, has now expanded to include additional accusations, further amplifying uncertainty around the stability of Arm's long-term royalty income.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)